Skip to main content

The Colon

  • Chapter
Source Control
  • 170 Accesses

Abstract

The large bowel contains up to 400 different bacterial species with concentrations of 1012–13/ml of feces. All require an intact intracolonic environment to prosper and stay in balance for the benefit of the host [1, 2]. The colon wall has a mature host defense system to keep bacteria in check and prevent their transmural migration into the peritoneal cavity. Structural bowel wall changes such as diverticula, inflammatory bowel disease, and cancer interfere with the colonic wall's ability to contain bacteria and a perforation may result. Similarly, impaired blood supply may diminish oxygen and nutrient supply to cellular structures of the colonic wall, impair colon function in general and cellular defense in particular. Perfusion deficits may progress to frank ischemia when several factors add up. Such a scenario may be seen when edema increases intra-abdominal pressure and reduces venous and arterial blood flow, and when surgical sutures strangulate perianastomotic arterioles [3]. Rather than a barrier and defense against bacterial invasion, the ischemic colon wall now serves as nutrient for bacterial growth, fostering their access to the peritoneal cavity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Clarke JS, Bartlett JG, Finegold SM, et al (1874) Bacteriology of the gut and its clinical implications. Western J Med 121:390–403

    Google Scholar 

  2. Finegold SM (1982) Microflora of the gastrointestinal tract. In: Wilson SE, Finegold SM, Williams RA (eds) Intra-abdominal infection. McGraw-Hill, New York, pp 1–22

    Google Scholar 

  3. Wittmann DH, Iskander GA (2000) The compartment syndrome of the abdominal cavity: a state-of-the-art review. J Intensive Care Medicine 15:201–220

    Article  Google Scholar 

  4. Kirschner M (1926) Die Behandlung der akuten eitrigen freien Bauchfellentzündung. Lan-genb Arch Chir 142:53–267

    Google Scholar 

  5. Tait, L (1883) Laparotomy for septic peritonitis. Brit Med J 1155:1–15

    Google Scholar 

  6. Rehn L (1902) Behandlung infectiös eitriger Processe im Peritoneum. Arch Klin Chir 67:1–56

    Google Scholar 

  7. Noetzel W (1908) Die operativer Behandlung der diffusen eitrigen Peritonitis Die operativer Behandlung der diffusen eitrigen Peritonitis. Verhandlungen der Dtsch Gesellschaft für Chir 34:638–707

    Google Scholar 

  8. Solomkin JS, Dellinger EP, Christou NV, Mason AD (1987) Design and conduct of antibiotic trials: a report of the Scientific Studies Committee of the Surgical Infection Society. Arch Surg 122:158–164

    Article  PubMed  CAS  Google Scholar 

  9. Ziegler E, Fisher CF, Sprung CL, Sträube RC, Sadoff JC, Foulke GE, Wortel CH, Fink MP, Dellinger RP, Teng NH, Allen IE, Berger HJ, Knatterud GL, LoBuglio AF, Smith CR (1991) HA-1A Sepsis Study Group. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonial antibody against endotoxin. N Engl J Med 324:429–436

    Article  PubMed  CAS  Google Scholar 

  10. Greenman RL, Schein RM, Martin MA, Wenzel RP, Maclntyre NR, Emmanuel G, Chmel H, Köhler RB, McCarthy M, Plouffe J (1991) A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. JAMA 266:1097–1102

    CAS  Google Scholar 

  11. Fisher CJ, Dhainaut JFA, Opal SM, Pribble JP, Balk RA, Slotman GJ, Iberti TJ, Rackow EC, Shapiro MJ, Greenman RL, Reines HD, Shelly MP, Thompson BW, LaBrecque JF, Catalano MA, Knaus WA, Sadoff JC(1994) Phase III rhIL-Ira Sepsis Syndrome Study Group. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. JAMA 271:1836–1843

    Article  PubMed  Google Scholar 

  12. Marshall JC, Lowry SF (1995) Evaluation of adequacy of source control in clinical trials. In: Sibbald_WJ, Vincent JL (eds) Clinical trials for the treatment of sepsis. Springer-Verlag, New York, pp 327–344

    Google Scholar 

  13. Wittmann DH, Aprahamian C, Bergstein JM (1990) Etappenlavage: advanced diffuse peritonitis managed by planned multiple laparotomies utilizing zippers, slide fastener, and velcro analogue for temporary abdominal closure. World J Surg 14:218–226

    Article  PubMed  CAS  Google Scholar 

  14. Wittmann DH (1996) Newer methods of operative therapy for peritonitis. In: Nyhus LM, Baker RJ, Fischer JE (eds) Mastery of surgery. Little, Brown, Boston, pp 146–152

    Google Scholar 

  15. Wittmann DH, Schein M, Condon RE (1996) Management of secondary peritonitis. Ann Surg 224:10–18

    Article  PubMed  CAS  Google Scholar 

  16. Wittmann DH (1998) Operative and nonoperative therapy of intraabdominal infections. Infection 26:335–341

    Article  PubMed  CAS  Google Scholar 

  17. Wittmann DH (1980) Chemotherapeutic principles in difficult-to-treat infections in surgery. I. Peritonitis. Infection 8:323–329

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Wittmann, D.H. (2003). The Colon. In: Schein, M., Marshall, J.C. (eds) Source Control. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55914-3_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55914-3_22

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-00408-0

  • Online ISBN: 978-3-642-55914-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics